UK-listed companies hit by Covid-19 are being given an additional lifeline as the Pre-Emption Group (PEG) extends the easing of its issuance guidelines, allowing more share capital to be raised from shareholders.
The …
Read More
The US Department of Labor (DoL) has thrown a new curveball into its approach to governing shareholder rights, questioning the need for asset owners to have their voices heard by companies at all.
Following …
Read More
Advisers to the Bayer-Monsanto takeover have been dragged into a lawsuit against the pharmaceuticals company that was originally filed in March.
Plaintiff Rebecca Haussmann, trustee of the Konstantin S. Haussmann Trust, filed …
Read More
Research conducted by two renowned Harvard academics has cast doubt on the commitments made a year ago by 181 CEOs affiliated to the Business Roundtable trade group.
Twelve months ago, business leaders …
Read More
A group of US business associations has called on the Senate to ratify legislation on boardroom diversity that was passed by the other chamber last year.
In an open letter to …
Read More
Despite claims from some of the world’s largest investors that moves to impose new proxy voting regulations would increase costs, the US financial regulator has pressed ahead with a series of …
Read More
The Bank of Spain has emerged as part of almost unanimous opposition to its government’s proposed introduction of so-called loyalty shares for listed companies.
According to El Pais, in its response to a consultation on a new securities and …
Read More
The role of proxy advisory firms and proxy plumbing in Canada could be set for a fundamental overhaul, following the publication of findings by the Capital Markets Modernisation Taskforce (CMMT).
In a wide-ranging remit, the taskforce has made …
Read More
Greek companies will soon be mandated to meet a 25% female quota on their boards following a landmark decision for gender diversity.
The quota requirement has been included as an amendment to the bill transposing the EU Shareholder Rights Directive …
Read More
Swiss pharmaceutical giant Novartis, a current and former subsidiary, has agreed to pay a total of $346.7m to reach settlements with the US Department of Justice (DOJ) and Securities and Exchange Commission (SEC) following investigations into bribery schemes.
The DOJ …
Read More